α-glucosidase inhibitor for the treatment of diabetes

被引：0
作者：
sun, sujuan
chen, yueteng
liu, quan
shen, zhufang
xie, mingzhi
机构：
来源：
ACTA PHARMACOLOGICA SINICA | 2006年 / 27卷
关键词：
diabetes; alpha - glucosidase inhibitor; suregade glomerulata;
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
引用
收藏
页码：306 / 306
页数：1
相关论文
共 50 条
  • [21] An α-Glucosidase Inhibitor from Drepananthus philippinensis
    Macabeo, Allan Patrick Gose
    Rubio, Peter Yuosef Moreno
    Alejandro, Grecebio Jonathan Duran
    Knorn, Matthias
    2ND HUMBOLDT KOLLEG IN CONJUNCTION WITH INTERNATIONAL CONFERENCE ON NATURAL SCIENCES 2014, HK-ICONS 2014, 2015, 14 : 36 - 39
  • [22] Antiviral Activity of Methylelaiophylin, an α-Glucosidase Inhibitor
    Lee, Doseung
    Woo, Jin-Kyu
    Kim, Donghern
    Kim, Minyoung
    Cho, Somi K.
    Kim, Jae Hoon
    Park, Se Pill
    Lee, Hyo Yeon
    Riu, Key Zung
    Lee, Dong-Sun
    JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY, 2011, 21 (03) : 263 - 266
  • [23] Vildagliptin Versus α-Glucosidase Inhibitor as Add-On to Metformin for Type 2 Diabetes: Subgroup Analysis of the China Prospective Diabetes Study
    Chen, Yulong
    Li, Quanmin
    Han, Ying
    Ji, Hongmei
    Gu, Mingjun
    Bian, Rongwen
    Ding, Weiguang
    Cheng, Jian
    Mu, Yiming
    DIABETES THERAPY, 2020, 11 (01) : 247 - 257
  • [24] A randomized controlled clinical trial of combination therapy for type 2 diabetes by vildagliptin, metformin, and α-glucosidase inhibitor
    Wang, Qiong
    Su, Yong
    Lv, Lifang
    INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2016, 36 (04) : 420 - 425
  • [25] EFFECT OF AN ALPHA-GLUCOSIDASE INHIBITOR COMBINED WITH SULFONYLUREA TREATMENT ON GLUCOSE-METABOLISM IN PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS
    OKADA, S
    ISHII, K
    TANOKUCHI, S
    HAMADA, H
    ICHIKI, K
    OTA, Z
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 1995, 23 (04) : 279 - 283
  • [26] The α-glucosidase inhibitor miglitol delays the development of diabetes and dysfunctional insulin secretion in pancreatic β-cells in OLETF rats
    Fukaya, Nanae
    Mochizuki, Kazuki
    Tanaka, Yutaro
    Kumazawa, Toshihiko
    Jiuxin, Zhu
    Fuchigami, Masahiro
    Goda, Toshinao
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2009, 624 (1-3) : 51 - 57
  • [27] LUSEOGLIFLOZIN SGLT2 Inhibitor Treatment of Diabetes
    Tiwari, A.
    DRUGS OF THE FUTURE, 2012, 37 (09) : 637 - 643
  • [28] Considerations when using alpha-glucosidase inhibitors in the treatment of type 2 diabetes
    Hedrington, Maka S.
    Davis, Stephen N.
    EXPERT OPINION ON PHARMACOTHERAPY, 2019, 20 (18) : 2229 - 2235
  • [29] DPP-4 inhibitor and alpha-glucosidase inhibitor equally improve endothelial function in patients with type 2 diabetes: EDGE study
    Nakamura, Kazufumi
    Oe, Hiroki
    Kihara, Hajime
    Shimada, Kenei
    Fukuda, Shota
    Watanabe, Kyoko
    Takagi, Tsutomu
    Yunoki, Kei
    Miyoshi, Toru
    Hirata, Kumiko
    Yoshikawa, Junichi
    Ito, Hiroshi
    CARDIOVASCULAR DIABETOLOGY, 2014, 13
  • [30] Effect of sodium-glucose cotransporter 2 inhibitor, empagliflozin, and α-glucosidase inhibitor, voglibose, on hepatic steatosis in an animal model of type 2 diabetes
    Kim, Ji-Won
    Lee, Ye-Jee
    You, Young-Hye
    Moon, Min Kyong
    Yoon, Kun-Ho
    Ahn, Yu-Bae
    Ko, Seung-Hyun
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2019, 120 (05) : 8534 - 8546
12345